PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.04

+2.6%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Solid who wrote (4481)	7/20/1998 10:59:00 AM
From: Hunter Vann	Read Replies (1) of 9523

Pharmacy Times Magazine Rx Product News Pfizer Inc. and UCB Pharma announced that the FDA has approved their antihistamine Zyrtec (cetirizine HCL) for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria in children as young as 2 years. When Zyrtec was initially approved in January 1996, it was for patients 12 years of age and older; in September 1996, the age was reduced to 6 years. Zyrtec is available in a 1 mg per 1 ml alcohol-free and dye-free, banana/grape-flavored syrup. It is also available in 5 and 10-mg tablets. Sorry if this was a repeat...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next